Derivados de Quinazolina e Quinolina
As quinazolinas e quinolinas são compostos heterocíclicos contendo nitrogénio, com estruturas aromáticas que desempenham um papel fundamental na síntese de fármacos com atividade anticancerígena, antimicrobiana e anti-inflamatória. Os seus derivados apresentam modificações estruturais que otimizam a biodisponibilidade e a seletividade, permitindo o desenvolvimento de novos princípios ativos para diversas aplicações terapêuticas. Estes compostos são utilizados na fabricação de APIs para o tratamento do câncer, infeções, doenças neurodegenerativas e cardiovasculares. Além disso, os derivados de quinazolina e quinolina são essenciais na investigação de inibidores enzimáticos e no desenvolvimento de moléculas bioativas inovadoras.
Na CymitQuimica, oferecemos derivados de quinazolina e quinolina de alta pureza para aplicações em síntese química, desenvolvimento farmacêutico e biotecnologia.
Foram encontrados 65576 produtos de "Derivados de Quinazolina e Quinolina"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Aminoethyl Fluvoxamine Dihydrochloride ((E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-{2-[(2-aminoethyl)amino]ethyl}oxime dihydrochloride)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFórmula:C17H26F3N3O2·2HClCor e Forma:White PowderPeso molecular:433.15107Aripiprazole Acid Analog (4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butanoic acid)
CAS:Lactams, nesoiFórmula:C13H15NO4Cor e Forma:White Off-White SolidPeso molecular:249.10011Carvedilol Related Compound C (1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C31H32N2O4Cor e Forma:Off-White PowderPeso molecular:496.23621Desmethoxyomeprazole
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C16H17N3O2SCor e Forma:Light Brown Grey Yellow PowderPeso molecular:315.10415Metoprolol Related Compound D ((+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl](1-methylethyl)amine hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C27H41NO6·HClCor e Forma:White PowderPeso molecular:475.29339Dichloroaniline (3,4-Dichloroaniline)
CAS:Aniline derivatives and their saltsFórmula:C6H5Cl2NCor e Forma:Light Brown Off-White CrystalsPeso molecular:160.9799Sodium Starch Glycolate Type A
CAS:Modified starches, nesoiFórmula:(C2H4O3)x·(Na)xCor e Forma:White Off-White PowderPeso molecular:515.6862Ondansetron Resolution Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:Off-White White PowderNaproxen Related Compound G ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFórmula:C14H14O3Cor e Forma:PowderPeso molecular:230.09429Bupropion Hydrochloride Related Compound F (1-(3-chlorophenyl)-1-hydroxypropan-2-one)
CAS:Aromatic ketone-alcohols and ketone-aldehydes, nesoiFórmula:C9H9ClO2Cor e Forma:Clear Yellow LiquidPeso molecular:184.02911Paroxetine System Suitability Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White Off-White PowderClozapine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C18H19ClN4Cor e Forma:Yellow PowderPeso molecular:326.12982Atazanavir Sulfate Valine Analog (methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15-methyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C37H50N6O7·H2SO4Cor e Forma:Off-White SolidPeso molecular:690.3741Methyl Acetate
CAS:Esters of acetic acid not elsewhere specified or includFórmula:C3H6O2Cor e Forma:Colorless Clear LiquidPeso molecular:74.08 g/molAtazanavir Ethyl Analog (methyl ((6S,11S,12S,15S)-12-benzyl-6-(tert-butyl)-11-hydroxy-16,16-dimethyl-4,7,14-trioxo-9-(4-(pyridin-2-yl)benzyl)-3-oxa-5,8,9,13-tetraazaheptadecan-15-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C39H54N6O7Cor e Forma:Off-White SolidPeso molecular:718.4054Argatroban
CAS:<p>Sulfonamides used as drugs</p>Fórmula:C23H36N6O5S·H2OCor e Forma:White Off-White PowderPeso molecular:526.25735Rotigotine Related Compound C ((S)-6-{[2-(Thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H19NOS·HClCor e Forma:Light Grey SolidPeso molecular:309.09541Rivaroxaban Related Compound J
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C38H36Cl2N6O10S2Cor e Forma:Off-White PowderPeso molecular:870.13114Naproxen Related Compound K (1-(6-Methoxynaphthalen-2-yl)ethanol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFórmula:C13H14O2Cor e Forma:White Crystalline PowderPeso molecular:202.09938Amiodarone Hydrochloride
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C25H29I2NO3·HClCor e Forma:White PowderPeso molecular:681.78 g/molFluvoxamine Maleate
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFórmula:C15H21F3N2O2·C4H4O4Cor e Forma:White Off-White Crystalline PowderPeso molecular:318.15551Nilotinib Related Compound A (3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C11H10F3N3Cor e Forma:Beige PowderPeso molecular:241.08268Oxprenolol Hydrochloride
CAS:Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFórmula:C15H23NO3·HCICor e Forma:White PowderPeso molecular:405.08009Butylated Hydroxytoluene
CAS:Monophenols, nesoiFórmula:C15H24OCor e Forma:White PowderPeso molecular:220.18272Rivaroxaban Open Ring Methylamine ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H21N3O3Cor e Forma:White Off-White SolidPeso molecular:279.15829Sunitinib Amide (5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide)
CAS:Lactams, nesoiFórmula:C16H14FN3O2Cor e Forma:Pale Yellow Yellow PowderPeso molecular:299.107Celecoxib Open Ring (4-((1,1,1-trifluoro-4-hydroxy-4-(p-tolyl)but-3-en-2-ylidene)amino)benzenesulfonamide)
Sulfonamides, nesoiFórmula:C17H15F3N2O3SCor e Forma:Yellow SolidPeso molecular:384.07555Cyclam (1,4,8,11-Tetraazacyclotetradecane)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C10H24N4Cor e Forma:White Beige PowderPeso molecular:200.2001Dabigatran Etexilate Related Compound A (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C34H40N6O6Cor e Forma:White SolidPeso molecular:628.30093Prasugrel Hydrochloride (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C20H20FNO3S·HClCor e Forma:White Off-White PowderPeso molecular:409.09147Rivaroxaban Desmorpholinone Analog ((S)-5-chloro-N-((3-(4-((2-hydroxyethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H18ClN3O4SCor e Forma:White Off-White SolidPeso molecular:395.07065Rivaroxaban Desthiophene Analog ((R)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H17N3O4Cor e Forma:White Off-White SolidPeso molecular:291.12191Saxagliptin Related Compound A (Saxagliptin pyrazine analog (1aS,4S,6aR,7aS)-6-amino-4-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]-1,1a,4,6a,7,7a-hexahydro-3H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C18H25N3O2Cor e Forma:White Fine PowderPeso molecular:315.19468Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C36H43NO6·H2OCor e Forma:White SolidPeso molecular:603.3196Omeprazole Related Compound I (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H19N3O5SCor e Forma:Light Brown Light Orange PowderPeso molecular:377.10454Phenylpropoxy Salmeterol (4-(1-hydroxy-2-((6-(3-phenylpropoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol; 4-{1-Hydroxy-2-[6-(3-phenylpropoxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C24H35NO4Cor e Forma:White Off-White SolidPeso molecular:401.25661Clioquinol Related Compound B (5,7-Dichloroquinolin-8-ol)
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFórmula:C9H5Cl2NOCor e Forma:White Off-White PowderPeso molecular:212.97482Duloxetine Related Compound A ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H19NOS·HClCor e Forma:Off-White SolidPeso molecular:297.11874Dabigatran Etexilate Related Compound C (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C34H41N7O5Cor e Forma:PowderPeso molecular:627.31692Duloxetine Related Compound F ((S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H19NOS·HClCor e Forma:Off-White PowderPeso molecular:333.09541Paliperidone Resolution Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White PowderR,R,S-Ezetimibe ((3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one)
CAS:Lactams not elsewhere specified or includedFórmula:C24H21F2NO3Cor e Forma:White Off-White SolidPeso molecular:409.148955-Hydroxymethylfurfural (5-(Hydroxymethyl)-2-furaldehyde)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFórmula:C6H6O3Cor e Forma:Yellow SolidPeso molecular:126.03169(S)-Glycidyl Phthalimide ((S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione)
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFórmula:C11H9NO3Cor e Forma:White Off-White SolidPeso molecular:203.05824Atazanavir Sulfate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C38H52N6O7·H2SO4Cor e Forma:White Pale Yellow PowderPeso molecular:802.35713Ofloxacin
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H20FN3O4Cor e Forma:Off-White Pale Yellow PowderPeso molecular:361.14378Clozapine Benzoyl Methylpiperazine Analog (1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C18H21ClN4OCor e Forma:Beige PowderPeso molecular:344.14039Atazanavir S,S,S,R-diastereomer (methyl [(5S,10S,11S,14R)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C38H52N6O7Cor e Forma:Pale Yellow SolidPeso molecular:704.38975
![Omeprazole Related Compound I (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478561.webp&w=3840&q=75)
